Merit Medical Systems, Inc. (MMSI)
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
MMSI's broad product portfolio, global expansion and strategic M&A support growth, while tariffs and China pressures remain key risks.
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
MMSI's broad portfolio, R&D investments and WRAPSODY opportunity support growth, while tariffs, China pressure and competition remain risks.
Should You Buy MMSI as Growth Improves but Valuation Stays Elevated?
Merit Medical's growth case is strengthening as launches, acquisitions and therapeutic products broaden its mix, but its premium valuation raises the execution bar.
Can MMSI Sustain Its 22.2% Gain in the Past Month as Growth Improves?
Merit Medical's 22.2% monthly rally gains support from stronger Q2 growth and a raised 2026 outlook, but valuation and tariff risks remain.
Here's Why Merit Medical (MMSI) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Merit Medical Eyes Next Growth Plan as Margins, Portfolio Review Take Center Stage
Merit Medical Systems NASDAQ: MMSI is focused on completing the objectives of its current long-range plan while developing its next strategic framework, Chief Financial Officer and Treasurer Raul Parra said during a Canaccord investor event.
Merit Medical Systems Eyes New Long-Range Plan as Growth, Margins Gain Momentum
Merit Medical Systems NASDAQ: MMSI is preparing its next long-range plan as the medical-device company works through a leadership transition, updates its reporting structure and seeks to build on recent revenue and margin momentum.
Merit Medical Systems, Inc. (MMSI) Presents at Bank of America SMID Cap Virtual Conference Transcript
Merit Medical Systems, Inc. (MMSI) Presents at Bank of America SMID Cap Virtual Conference Transcript
MMSI Q2 Earnings & Revenues Beat Estimates, '26 Guidance Raised
Merit Medical's Q2 adjusted EPS jumps 18% as revenues rise 9.5%, margins expand and 2026 guidance increases after broad product growth.
Merit Medical Systems, Inc. (MMSI) Q2 2026 Earnings Call Transcript
Merit Medical Systems, Inc. (MMSI) Q2 2026 Earnings Call Transcript
Merit Medical (MMSI) Surpasses Q2 Earnings and Revenue Estimates
Merit Medical (MMSI) came out with quarterly earnings of $1.19 per share, beating the Zacks Consensus Estimate of $0.96 per share. This compares to earnings of $1.01 per share a year ago.
Merit Medical (MMSI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Merit Medical (MMSI) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
